DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab
Clinical trial NCT03688178 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03688178
- Sponsor
- Annick Desjardins, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-26
- Primary completion
- 2027-03-31
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.